French Energy Services Stock News

What the latest trading statement tells you about Neurones Neurones (ENXTPA:NRO) just reported unaudited 2025 figures, with revenue of €857.2 million for the year and €225 million in Q4, and a higher operating margin in the second half. See our latest analysis for Neurones. Despite the stronger 2025 trading statement, the recent performance has been weak, with a 30 day share price return showing a 13.7% decline and a 1 year total shareholder return indicating a 22.5% loss, which suggests...

Assystem (EPA:ASY) has had a rough week with its share price down 8.5%. But if you pay close attention, you might find...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

The board of Signaux Girod S.A. ( EPA:ALGIR ) has announced that it will pay a dividend on the 9th of April, with...

Why Sartorius Stedim Biotech is Back on Investors’ Radar Sartorius Stedim Biotech (ENXTPA:DIM) recently issued 2026 sales growth guidance of around 5% to 9%, providing a fresh data point that gives investors a clearer anchor for expectations after a difficult few years. See our latest analysis for Sartorius Stedim Biotech. The 4.01% 1 day share price return to €174.95 came after the 2026 sales growth guidance and followed a 17.98% 30 day share price decline. The 5 year total shareholder...

In the past week, Renault attracted attention ahead of its 18 February 2026 earnings report, as investors focused on potential margin recovery in its electric vehicle and financing businesses. This renewed interest highlights how quickly sentiment can shift when a company’s profitability in newer segments, such as EVs and financial services, appears poised for change. We’ll now examine how this optimism around electric vehicle margin recovery could influence Renault’s broader investment...

If you are wondering whether Compagnie de Saint-Gobain shares offer solid value at around €90.86, the key is to look past the headline price and focus on how the market is actually pricing the business. The stock has returned 2.9% over the past week and 8.2% over the past month, while the 1 year return sits at a 3.9% decline and the 3 year and 5 year returns are 81.5% and 141.0% respectively. This gives a mixed picture for anyone trying to judge risk and reward. Recent news coverage around...

Sanofi (ENXTPA:SAN) announced that its Board of Directors will not renew CEO Paul Hudson's mandate. Belén Garijo, former Merck KGaA CEO and previous Sanofi executive, has been appointed as the incoming CEO. The leadership change comes at a time of R&D, productivity, and US vaccine business challenges for the company. Sanofi sits at the crossroads of big pharma and vaccines, with investors watching closely as it responds to recent pipeline setbacks and pressure in its US vaccine operations...

Why Danone stock is back on investors’ radar Danone (ENXTPA:BN) is drawing fresh attention after recent share price swings, with the stock roughly flat over the past day but showing mixed moves over the past week, month, and past 3 months. See our latest analysis for Danone. Zooming out, Danone’s recent 7 day share price return of 4.57% comes after a softer patch, with a 90 day share price return of 7.59%. Meanwhile, the 1 year total shareholder return of 10.78% and 3 year total shareholder...

What the latest guidance means for Soitec’s revenue outlook Soitec (ENXTPA:SOI) has put fresh numbers on the table, pairing a sharp year-on-year Q3 revenue drop with an outlook for around 20% revenue growth in Q4 2026 versus the previous quarter at constant exchange rates and scope. For you as an investor, that mix of weak annual comparison and sequential improvement, along with the new guidance, provides a basis for reassessing how the market might be thinking about the company’s earnings...

Why the CEO change at ERAMET (ENXTPA:ERA) matters for shareholders Eramet’s Board removed Chief Executive Officer Paulo Castellari on February 1, citing differences in operating methods, and appointed Chairwoman Christel Bories as interim CEO while a search process for a permanent replacement continues. For you as a shareholder or potential investor, sudden leadership changes can raise questions about execution, capital allocation and how consistently current projects, such as the lithium...

Schneider Electric (ENXTPA:SU) is back in focus after a run of product news, including EcoStruxure Foxboro Software Defined Automation, presented as the industry’s first open, software-defined distributed control system for complex industrial operations. See our latest analysis for Schneider Electric. These automation and grid software launches have arrived alongside firm share price momentum, with Schneider Electric’s €262.9 stock posting an 11.8% 1 month share price return and a 124.83% 5...

Airbus (ENXTPA:AIR) is back in focus after Air Canada confirmed a firm order for eight A350-1000 widebody jets, a sizeable long-haul commitment that underscores ongoing demand for next generation widebody aircraft. See our latest analysis for Airbus. At a share price of €192.42, Airbus has seen a 1-day share price return of 1.05% and a 7-day share price return of 0.59%. Its 30-day and year-to-date share price returns are declines of 11.49% and 5.54%, respectively, even as recent widebody...

Safran has opened a major landing gear production plant in Morocco focused on Airbus A320 programs. The facility is designed to support global aerospace supply chains and use mainly decarbonized energy. The project is expected to create hundreds of local jobs and expand Safran's manufacturing footprint. Safran, listed as ENXTPA:SAF, is adding this Moroccan plant at a time when its shares trade around €332.8. The company has seen share price returns of 8.1% over the past week and 36.8% over...

Eutelsat Communications (ENXTPA:ETL) H1 2026 Results: Losses Persist as Revenue Holds Just Below Prior Levels Eutelsat Communications (ENXTPA:ETL) has reported H1 2026 results with total revenue of €637.5 million and a basic EPS loss of €0.44, alongside trailing twelve month revenue of €1.23 billion and a basic EPS loss of €0.85. The company has seen revenue move from €640.4 million in H2 2024 to €606.2 million in H1 2025 and then to €637.5 million in H2 2025, while basic EPS has stayed in...

Why Unibail-Rodamco-Westfield is on investors’ radar today Unibail-Rodamco-Westfield (ENXTPA:URW) has drawn attention after recent share price moves, with the stock last closing at €99.46. That price now sits against a published intrinsic discount of 34.41%. See our latest analysis for Unibail-Rodamco-Westfield. Recent trading has been supported by a 1-month share price return of 8.63% and a 3-month share price return of 9.15%. The 1-year total shareholder return of 29.48% and 5-year total...

Rexel S.A. ( EPA:RXL ) will pay a dividend of €1.20 on the 13th of May. This means the annual payment will be 3.3% of...

Legrand SA ( EPA:LR ) will increase its dividend on the 2nd of June to €2.38, which is 8.2% higher than last year's...

When close to half the companies in France have price-to-earnings ratios (or "P/E's") below 16x, you may consider Rémy...

Statistically speaking, long term investing is a profitable endeavour. But that doesn't mean long term investors can...

If you are wondering whether Atos at €44.50 is priced for a turnaround or still carrying too much baggage, you are not alone. This article focuses squarely on what the current share price implies about value. The stock has been volatile, with a 7.5% decline over the last 7 days and a 21.7% decline over the past month. It still shows a 64.8% return over the last year after very large losses over 3 and 5 years, at 95.7% and 99.0% respectively. Recent headlines around Atos have mainly centered...

Key Insights Given the large stake in the stock by institutions, Valeo's stock price might be vulnerable to their...

Shareholders might have noticed that LVMH Moët Hennessy - Louis Vuitton, Société Européenne ( EPA:MC ) filed its annual...

Eurofins Scientific (ENXTPA:ERF) is back on some investors’ radars after recent share price swings, with returns ranging from a 9.2% decline over the past month to an 11.5% gain in the past 3 months. See our latest analysis for Eurofins Scientific. Looking beyond the recent swings, Eurofins Scientific’s 1 month share price return of 9.23% and 3 month share price return of 11.48% sit alongside a 1 year total shareholder return of 32.69%. This suggests momentum has been recovering after a...